ropinirole prolonged-release (Ropinirole PR)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ropinirole prolonged-release (Ropinirole PR), covering 2012-08-07 to 2012-08-07. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa [Phase 3]